Filip Farnebo
- Molecular Biology top 5%
- Oncology top 2%
- Nephrology top 0.5%
- Epidemiology top 5%
- Genetics top 5%
- Co-authors
- Catharina LarssonBin Tean TehFredrik LannerLars‐Ove FarneboKerstin SandelinSoili KytöläRichard C. MulliganJudah Folkman
- Topics
- Parathyroid Disorders and Treatments (15 papers)Neuroendocrine Tumor Research Advances (13 papers)Pancreatic and Hepatic Oncology Research (10 papers)
- Cited by
- NephrologyOncologyNeurology
- Journals
- Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaJournal of the American College of Cardiology
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Filip Farnebo
70 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.4k
- Oncology 1.0k
- Nephrology 764
- Epidemiology 720
- Genetics 632
Countries citing papers authored by Filip Farnebo
This map shows the geographic impact of Filip Farnebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Farnebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Farnebo more than expected).
Fields of papers citing papers by Filip Farnebo
This network shows the impact of papers produced by Filip Farnebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Farnebo. The network helps show where Filip Farnebo may publish in the future.
Co-authorship network of co-authors of Filip Farnebo
This figure shows the co-authorship network connecting the top 25 collaborators of Filip Farnebo. A scholar is included among the top collaborators of Filip Farnebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Farnebo. Filip Farnebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 30 | |
| 3 | 9 | |
| 4 | 6 | |
| 5 | 23 | |
| 6 | 35 | |
| 7 | 150 | |
| 8 | 19 | |
| 9 | 111 | |
| 10 | 1 | |
| 11 | 33 | |
| 12 | 10 | |
| 13 | 35 | |
| 14 | 12 | |
| 15 | 20 | |
| 16 | 33 | |
| 17 | 76 | |
| 18 | 100 | |
| 19 | 66 | |
| 20 | 31 |
About Filip Farnebo
Filip Farnebo is a scholar working on Nephrology, Neurology and Oncology, having authored 71 papers that have together received 3.4k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (15 papers), Neuroendocrine Tumor Research Advances (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). The work is most often cited by research in Nephrology (764 citations), Oncology (1.0k citations) and Neurology (399 citations). Filip Farnebo has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Catharina Larsson, Bin Tean Teh, Fredrik Lanner, Lars‐Ove Farnebo, Kerstin Sandelin, Soili Kytölä, Richard C. Mulligan, Judah Folkman, Martin Halle and Per Tornvall. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.